PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsSeptic shock
MeSH D012772 - septic shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018805:Sepsis
26 Companies
9 Drugs
$
Success rate
D018746:Systemic inflammatory response syndrome
0 Companies
0 Drugs
Success rate
D012772: 
Septic shock
127 Companies
28 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MPhenylephrine, Isoproterenol Duo-medihaler  1982-01-01   
Epinephrine Medihaler-epi  1982-01-01   
Abbott BiotherapeuticsLidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
Accord HealthcarePhenylephrine Phenylephrine  2020-07-01   
Adamis PharmaceuticalsEpinephrine Symjepi 2036-10-20 2017-06-15   
Alcon ResearchPhenylephrine, Cyclopentolate Cyclomydril  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1986-11-17   
Phenylephrine Phenylephrine  2015-01-15   
AllerganPhenylephrine, Pyrilamine Prefrin-a  1982-01-01   
Lidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
90%
19/21
Phase 2
70%
42/60
Phase 3
42%
35/84
Approved: 5Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Lidocaine,
Epinephrine,
Isoproterenol,
Levosimendan,
Icosapent,
Doconexent,
Riboprine,
Retinol
AbbVie
Dexamethasone,
Isoproterenol
Alcon Research
Dexamethasone
Allergan
Dexamethasone,
Epinephrine,
Lidocaine,
Phenylephrine
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use